We serve Chemical Name:Dehydroheliamine CAS:3382-18-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Dehydroheliamine
CAS.NO:3382-18-1
Synonyms:6,7-dimethoxy-3,4-dihydro-2H-isoquinoline;2,3-dihydro-5,6-dimethoxyisoquinoline;6,7-Dimethoxy-3,4-dihydroisoquinoline;Isoquinoline, 3,4-dihydro-6,7-dimethoxy-;3,4-dihydro-6,7-dimethoxyisiquinoline;Dehydroheliamine;3,4-dihydro-6,7-dimethoxyisoquinoline;3,4-dihydro-6,7-dimethoxylsoquinoline;6,7-Dimethoxy-3,4-dihydro-isoquinoline
Molecular Formula:C11H13NO2
Molecular Weight:191.226
HS Code:2933499090
Physical and Chemical Properties:
Melting point:39-40℃
Boiling point:322.9±42.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.549
PSA:30.82000
Exact Mass:191.094635
LogP:1.63
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6,7-dimethoxy-3,4-dihydro-2H-isoquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6,7-Dimethoxy-3,4-dihydro-isoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6,7-Dimethoxy-3,4-dihydroisoquinoline Use and application,6,7-Dimethoxy-3,4-dihydroisoquinoline technical grade,usp/ep/jp grade.
Related News: There are limited treatment options for the disorder. Women with advanced endometrial cancer who are not candidates for curative therapy have a survival rate of just 17% {3-[4-(3-Methoxy-phenyl)-piperidin-1-yl]-propyl}-methyl-amine manufacturers “His strong track record of success and deep experience of fast-moving consumer goods and consumer health, proven at P&G, Novartis and GSK, means he is the right choice” to lead the consumer health unit as an independent company, GSK Chairman Jonanthan Symonds said of McNamara in the statement. 4-(3-{1-[6-(2,6-diethyl-phenyl)-4-ethoxy-pyridin-3-yl]-butoxy}-benzyl)-morpholine suppliers About eight months after originally teaming up on neuromuscular diseases, Takeda and PeptiDream have expanded the pact to include several central nervous system targets, while revealing the tie-up could be worth more than $3.5 billion. dimethyl (S)-(4-methyl-3-((4-methylphenyl)sulfonamido)-2-oxopentyl)phosphonate vendor & factory.
